Q3 FY2026 · ended Sep 30, 2026 · Revenue $154.45M, +15.0% YoY · Filed Nov 4, 2026
AtriCure, Inc. (ATRC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $154.4 million and net income of $4.1 million. Free cash flow was $23.9 million. As of Sep 30, 2026 it held $187.0 million in cash and investments and $96.7 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ATRC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mason, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1323885
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $154.4M | $153.6M | $141.2M | $140.5M | $134.3M |
| Operating income | $4.4M | $9.7M | $526,000 | $2.5M | $208,000 |
| Net income | $4.1M | $9.0M | $108,000 | $1.8M | -$267,000 |
| Diluted EPS | $0.08 | $0.18 | $0.00 | $0.04 | -$0.01 |
| Operating cash flow | $30.3M | $22.2M | -$4.0M | $20.0M | $26.7M |
| Free cash flow | $23.9M | $18.4M | -$7.8M | $18.4M | $24.1M |
| Total assets | $717.5M | $676.6M | $644.0M | $654.2M | $635.4M |
| Total liabilities | $184.3M | $160.2M | $152.3M | $162.2M | $158.9M |
| Stockholders' equity | $533.2M | $516.4M | $491.7M | $491.9M | $476.5M |
| Cash and investments | $187.0M | $167.8M | $146.2M | $167.4M | $147.9M |
| Total debt | $96.7M | $74.1M | $74.8M | $76.4M | $76.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Jul 27, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 19, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
All 1001 AtriCure, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.